BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16703748)

  • 1. Does the evidence support the use of concurrent chemoradiotherapy as a standard in the management of locally advanced cancer of the cervix, especially in developing countries?
    Datta NR; Agrawal S
    Clin Oncol (R Coll Radiol); 2006 May; 18(4):306-12. PubMed ID: 16703748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis.
    Datta NR; Stutz E; Liu M; Rogers S; Klingbiel D; Siebenhüner A; Singh S; Bodis S
    Gynecol Oncol; 2017 May; 145(2):374-385. PubMed ID: 28188016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades.
    Sagae S; Toita T; Matsuura M; Saito M; Matsuda T; Sato N; Shimizu A; Endo T; Fujii M; Gaffney DK; Small W
    Int J Gynecol Cancer; 2023 Aug; 33(8):1295-1303. PubMed ID: 37041022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-institutional phase II clinical study of concurrent chemoradiotherapy for locally advanced cervical cancer in East and Southeast Asia.
    Kato S; Ohno T; Thephamongkhol K; Chansilpa Y; Yuxing Y; Devi CR; Bustam AZ; Calaguas MJ; de los Reyes RH; Cho CK; Dung TA; Supriana N; Mizuno H; Nakano T; Tsujii H
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):751-7. PubMed ID: 19836154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments in chemoradiotherapy for locally advanced cancer of the cervix.
    Kim RY; Alvarez RD
    Oncology (Williston Park); 2000 Sep; 14(9):1327-31, 1335; discussion 1336-8. PubMed ID: 11033830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor shrinkage before intracavitary brachytherapy for cancer of the cervix: radiotherapy alone versus concurrent chemoradiotherapy.
    Kim RY; Spencer SA
    Cancer J; 2000; 6(6):377-80. PubMed ID: 11131487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
    Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
    Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiation versus radiotherapy alone in cervical carcinoma: A randomized phase III trial.
    Srivastava K; Paul S; Chufal KS; Shamsundar SD; Lal P; Pant MC; Bhatt M; Singh S; Gupta R
    Asia Pac J Clin Oncol; 2013 Dec; 9(4):349-56. PubMed ID: 23710586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the treatment of gynecologic malignancies. Part 1: Cancers of the cervix and vulva.
    Kim RY; Alvarez RD; Omura GA
    Oncology (Williston Park); 2002 Nov; 16(11):1510-7, 1521; discussion 1522-4, 1528, 1530. PubMed ID: 12469929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly cisplatin 20 mg/m2 in patients with carcinoma of cervix receiving pelvic radiotherapy at Srinagarind Hospital: a randomized controlled trial.
    Punushapai U; Yuenyao P; Chumworathayi B; Luanratanakorn S; Udomthavornsuk B
    Asian Pac J Cancer Prev; 2010; 11(1):201-7. PubMed ID: 20593957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Standards, options and recommendations: concomitant radiochemotherapy for cancer of the cervix: a critical analysis of the literature and update of SOR].
    Haie-Meder C; Fervers B; Chauvergne J; Fondrinier E; Lhommé C; Guastalla JP; Resbeut M
    Bull Cancer; 1999 Oct; 86(10):829-41. PubMed ID: 10572234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of concurrent chemoradiotherapy with high-dose-rate intracavitary brachytherapy in patients with locally advanced uterine cervical cancer: efficacy and toxicity of a low cumulative radiation dose schedule.
    Toita T; Kitagawa R; Hamano T; Umayahara K; Hirashima Y; Aoki Y; Oguchi M; Mikami M; Takizawa K;
    Gynecol Oncol; 2012 Aug; 126(2):211-6. PubMed ID: 22555110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix.
    Green J; Kirwan J; Tierney J; Symonds P; Fresco L; Williams C; Collingwood M
    Cochrane Database Syst Rev; 2001; (4):CD002225. PubMed ID: 11687152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cancer of the uterine cervix: combination of radiotherapy and cisplatin chemotherapy (chemoradiotherapy) is superior to radiotherapy alone in local advanced stages].
    Mazeron JJ
    Bull Cancer; 1999 Mar; 86(3):247-8. PubMed ID: 10847719
    [No Abstract]   [Full Text] [Related]  

  • 17. Concurrent Cisplatin-Based Chemoradiation in Squamous Cell Carcinoma of Cervix.
    Hashmi H; Maqbool A; Ahmed S; Ahmed A; Sheikh K; Ahmed A
    J Coll Physicians Surg Pak; 2016 Apr; 26(4):302-5. PubMed ID: 27097702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix.
    Koumantakis E; Haralambakis Z; Koukourakis M; Mazonakis M; Haldeopoulos D; Papageorgiou N; Livas V; Froudarakis G; Varveris H
    Br J Radiol; 1998 May; 71(845):552-7. PubMed ID: 9691902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concurrent chemotherapy and radiation therapy in primary cancer of the cervix.
    Schilder JM; Stehman FB
    Curr Oncol Rep; 1999 Sep; 1(1):41-6. PubMed ID: 11122796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
    Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
    Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.